Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
ThermoGenesis enters technology license agreement with Boyalife Genomics
ThermoGenesis entered into a license and technology access agreement with Boyalife Genomics, providing a U.S. license to certain existing and future know-how and intellectual property relating to cell manufacturing and related processes.
2021
ThermoGenesis reports first-quarter 2021 results
ThermoGenesis Holdings reported financial and operating results for the first quarter ended March 31, 2021, and provided a corporate strategic update.
2020
ThermoGenesis begins shipping its COVID-19 antibody test kit
ThermoGenesis said it began shipping its SARS-CoV-2 IgM/IgG Antibody Fast Detection Test Kit in May to fill pre-orders and other incoming orders.
2020
ThermoGenesis announces $3.5 million registered direct offering
ThermoGenesis Holdings announced definitive agreements with institutional investors for a registered direct offering of 1,000,002 shares at $3.50 per share, with gross proceeds expected to be approximately $3.5 million. The offering closing was expected on or about March 27, 2020, subject to customary conditions.